Home
Neogene Therapeutics

Neogene Therapeutics Market Share Analysis for April 2026

pushing the frontier by pioneering next-generation, neoantigen-targeting engineered t cell receptor therapies for solid cancers

Health > Biotechnology and Pharmaceuticals

Domainneogene.com

Year Founded2018

Employees51 - 200

Annual Revenue$2M - $5M

Neogene Therapeutics

Neogene Therapeutics (including company regionals)

neogene.com

See more website traffic and engagement information

Neogene Therapeutics Revenue up to April 2026 is 2M - 5M

revenue generated by Neogene Therapeutics top domains

Neogene Therapeutics top domains revenue over 3 years

Revenue for Neogene Therapeutics top domains

neogene.com2M - 5M

See more with Sales Intelligence

Total visits to Neogene Therapeutics's top domains

Understand Neogene Therapeutics market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Neogene Therapeutics's top domains

Analyze Neogene Therapeutics engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Neogene Therapeutics's top domains

See how Neogene Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Neogene Therapeutics top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Neogene Therapeutics

These are the website technologies, by industry, used by Neogene Therapeutics top domains

Widget (6)

Twemoji

Content Management System (3)

WordPress

Mobile (2)

Meta Viewport

Advertising (1)

PubMatic

More Technologies

6

See all

News & Signals from Neogene Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsNeogene Therapeutics, Inc. hires Han."We are very excited to welcome Han to Neogene, who further complements our leadership team with his broad skill set.

NewsNeogene Therapeutics, Inc. hired Raphaël Rousseau as Chief Medical Officer on Dec 16th '21.SANTA MONICA, Calif., and AMSTERDAM, December 16, 2021 - Neogene Therapeutics, Inc., a preclinical stage biotechnology company pioneering a new class of fully individualized T cell receptor (TCR) therapies to treat cancer, today announced the appointment of Raphaël Rousseau, M.D., Ph.D. as Chief Medical Officer.